Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership2,720 shares
Latest Disclosed Value $ 1,214,589
IFP Advisors, Inc reports 11.75% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 2,720 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $1,214,589 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 3,082 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -11.75% during the quarter. The current value of the position is $1,165,085 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F VERTEX PHARMACEUTICALS cs 92532F100 2,720 -362 -11.75 1,215 -13.10 0.0252
2026-02-06 2025-12-31 13F VERTEX PHARMACEUTICALS cs 92532F100 3,082 797 34.88 1,397 56.26 0.0314
2026-02-06 2025-09-30 13F/A-1 VERTEX PHARMACEUTICALS cs 92532F100 2,285 695 43.71 895 11.75 0.0232
2025-12-02 2025-09-30 13F VERTEX PHARMACEUTICALS cs 92532F100 2,188 598 937 0.0242
2025-07-24 2025-06-30 13F VERTEX PHARMACEUTICALS cs 92532F100 1,590 -1,074 -40.32 800 -38.27 0.0228
2025-05-05 2025-03-31 13F VERTEX PHARMACEUTICALS cs 92532F100 2,664 -92 -3.34 1,296 16.44 0.0400
2025-02-04 2024-12-31 13F VERTEX PHARMACEUTICALS cs 92532F100 2,756 909 49.21 1,114 29.72 0.0365
2025-02-04 2024-09-30 13F VERTEX PHARMACEUTICALS cs 92532F100 1,847 -457 -19.84 859 -20.48 0.0310
2024-07-30 2024-06-30 13F VERTEX PHARMACEUTICALS cs 92532F100 2,304 328 16.60 1,080 30.79 0.0428
2024-07-30 2024-03-31 13F VERTEX PHARMACEUTICALS cs 92532F100 1,976 -159 -7.45 826 -4.95 0.0362
2024-01-09 2023-12-31 13F VERTEX PHARMACEUTICALS cs 92532F100 2,135 354 19.88 869 40.23 0.0410
2023-10-12 2023-09-30 13F VERTEX PHARMACEUTICALS cs 92532F100 1,781 -73 -3.94 619 -5.06 0.0278
2023-08-14 2023-06-30 13F/A-1 VERTEX PHARMACEUTICALS cs 92532F100 1,854 289 18.47 652 175.11 0.0273
2023-08-04 2023-06-30 13F VERTEX PHARMACEUTICALS cs 92532F100 1,854 289 282 0.0130
2023-04-18 2023-03-31 13F VERTEX PHARMACEUTICALS cs 92532F100 1,565 -5,339 -77.33 238 23,600.00 0.0104
2023-02-07 2022-12-31 13F VERTEX PHARMACEUTICALS cs 92532F100 6,904 -1,343 -16.28 1 -99.92 0.0293
2022-11-08 2022-09-30 13F VERTEX PHARMACEUTICALS cs 92532F100 8,247 711 9.43 1,288 10.46 0.0336
2022-09-06 2022-06-30 13F/A-1 VERTEX PHARMACEUTICALS cs 92532F100 7,536 0 0.00 1,166 0.00 0.0374
2022-09-06 2022-03-31 13F/A-1 VERTEX PHARMACEUTICALS cs 92532F100 7,536 6,426 578.92 1,166 375.92 0.0374
2022-08-08 2022-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,151 41 180 0.0037
2022-01-12 2021-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,110 -54 -4.64 245 15.02 0.0048
2021-10-06 2021-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,164 154 15.25 213 7.58 0.0043
2021-07-13 2021-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,010 -814 -44.63 198 -50.50 0.0041
2021-04-30 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,824 -421 -18.75 400 -24.95 0.0078
2021-01-25 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 2,245 19 0.85 533 -13.05 0.0216
2020-10-29 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 2,226 945 73.77 613 64.78 0.0366
2020-08-05 2020-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,281 286 28.74 372 66.82 0.0295
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 995 309 45.04 223 46.71 0.0225
2020-01-17 2019-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 686 -66 -8.78 152 21.60 0.0114
2019-11-07 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 752 300 66.37 125 50.60 0.0084
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALSINC Stock 92532F100 452 -954 -67.85 83 -63.44 0.0113
2019-06-03 2018-12-31 13F/A-10 VERTEX PHARMACEUTICALS IN Stock 92532F100 1,406 -230 -14.06 227 -27.94 0.0138
2019-01-23 2018-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,406 -230 227 0.0138
2019-06-03 2018-09-30 13F/A-9 VERTEX PHARMACEUTICALS IN Stock 92532F100 1,636 577 54.49 315 75.00 0.0128
2018-10-25 2018-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,636 577 315 0.0128
2019-06-03 2018-06-30 13F/A-8 VERTEX PHARMACEUTICALS IN Stock 92532F100 1,059 345 48.32 180 68.22 0.0076
2018-08-07 2018-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,059 151 180
2019-06-03 2018-03-31 13F/A-7 VERTEX PHARMACEUTICALS INC COM Stock 92532F100 714 0 0.00 107 0.00 0.0049
2018-05-09 2018-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 908 194 148
2019-06-03 2017-12-31 13F/A-6 VERTEX PHARMACEUTICALS INC COM Stock 92532F100 714 -148 -17.17 107 -18.32 0.0049
2018-01-24 2017-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 714 -148 107
2017-10-30 2017-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 862 158 22.44 131 43.96 0.0052
2019-06-03 2017-06-30 13F/A-5 VERTEX PHARMACEUTICALS INC COM Stock 92532F100 704 -2 -0.28 91 18.18 0.0039
2017-07-31 2017-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 704 -2 91
2019-06-03 2017-03-31 13F/A-4 VERTEX PHARMACEUTICALS INC COM Stock 92532F100 706 -65 -8.43 77 35.09 0.0034
2017-04-26 2017-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 706 -65 77
2019-06-03 2016-12-31 13F/A-3 VERTEX PHARMACEUTICALS INC COM Stock 92532F100 771 108 16.29 57 -1.72 0.0028
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 771 108 57
2016-11-04 2016-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 663 -9 -1.34 58 0.00 0.0030
2019-06-03 2016-06-30 13F/A-2 VERTEX PHARMACEUTICALS INC COM Stock 92532F100 672 220 48.67 58 -30.12 0.0032
2016-08-22 2016-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 672 220 58
2019-06-03 2016-03-31 13F/A-1 VERTEX PHARMACEUTICALSINC Stock 92532F100 452 -315 -41.07 83 -14.43 0.0113
2016-05-02 2016-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 701 -66 56
2016-02-11 2015-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 767 767 97 0.0065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.